Legacy Radium and Orphan Sources in Healthcare

Decades after radium brachytherapy was abandoned, radium-226 sources still turn up in healthcare facilities—in old safes, forgotten storage rooms, and the inventories of departed licensees—and finding one is a regulated event, not a curiosity. Since the Energy Policy Act of 2005, discrete sources of radium-226 are byproduct material, so a legacy radium needle is now licensable radioactive material with safety, security, and disposal obligations attached.

Legacy and orphan sources are a recurring problem precisely because they outlast the people and programs that created them. Radium-226 has a half-life measured in millennia; the practice that used it ended, but the material did not. Hospital mergers, department closures, renovations, and the retirement of long-serving staff repeatedly surface sources that no one on the current team remembers acquiring.

This article explains what legacy and orphan sources are, why radium-226 in particular is hazardous, how the regulatory picture changed in 2005, and the practical steps—identification, security, notification, and disposal—a facility should take. DRPS supports this work through radioactive material license support and RSO program guidance.

Introduction

An "orphan source" is a radioactive source that has fallen outside regulatory control, and a "legacy source" is a disused source left over from an earlier era of practice. The NRC describes orphan sources as sealed sources that are either uncontrolled and require removal to protect public health, or controlled but without an identifiable responsible party. ⁵ In healthcare the archetypal legacy source is radium-226 brachytherapy material.

From the early twentieth century through the mid-century, radium-226 was the workhorse of brachytherapy, used as needles, tubes, and plaques for interstitial and intracavitary treatment. It was progressively replaced by safer, purpose-made isotopes—cesium-137, cobalt-60, and later iridium-192—because radium's long half-life, radon daughter, and high photon energies made it hazardous to handle and dispose of. ⁸ The clinical transition was largely complete decades ago, but the physical sources were frequently retained, stored, and then forgotten rather than dispositioned.

The result is a slow trickle of discoveries: a lead pig in a sub-basement, a radium needle in a safe, a check source with no paperwork. Each one is a radiation-safety and regulatory event that a facility must be prepared to handle.

Topic Explanation

What makes a source "legacy" or "orphan"

The two terms overlap but are not identical:

• Legacy source: a disused sealed source from a superseded practice, still physically present—radium brachytherapy sources are the classic case, but old calibration and check sources, and sources from discontinued modalities, also qualify.
• Orphan source: a source outside regulatory control, whether because it was abandoned, lost and found, or left behind by a licensee who no longer exists. ⁵

A legacy radium source sitting in a licensed facility's safe, properly inventoried, is a legacy source but not orphaned. The same needle discovered loose in a renovation, with no records and no responsible licensee, is both. The distinction matters because it determines who is responsible and which recovery pathway applies.

Why radium-226 is uniquely troublesome

Radium-226 concentrates several hazards in one material:

• It effectively never decays away. With a half-life of about 1,600 years, a radium source is as active today as it was when it was manufactured a century ago. ¹⁰
• It emits alpha particles and produces radon gas. Radium-226 decays by alpha emission to radon-222, a radioactive noble gas. If the sealed encapsulation has corroded or failed—common in sources that are many decades old—radon can escape and its short-lived daughters can contaminate the storage container and surroundings. ¹⁰
• Its decay chain is a gamma source. Radon-222's daughters, including lead-214 and bismuth-214, emit penetrating gamma rays, so an intact radium source still presents an external-dose hazard requiring shielding and distance. ¹⁰

A found radium source is therefore both a contamination hazard (potential radon leakage and loose daughter products) and an external-dose hazard (penetrating gamma from the decay chain). It must be treated as both until a survey and leak test prove otherwise.

Key Technical Principles

The specific activity of radium-226

The sheer persistence of radium is best appreciated through its specific activity. Activity relates to the number of atoms $N$ and the decay constant $\lambda$ by:

For radium-226, $T_{1/2}\approx 1,600$ years $\approx 5.05\times 10^{10}$ seconds, so:

One gram of radium-226 contains $N=N_A/M=(6.022\times 10^{23})/226\approx 2.67\times 10^{21}$ atoms, giving a specific activity of:

This is not a coincidence: the curie was originally defined as the activity of one gram of radium-226. The calculation makes the disposal problem concrete—a small, gram-scale radium source carries roughly a curie of long-lived activity that will persist essentially unchanged for thousands of years. There is no "letting it decay"; it must be physically removed and consolidated.

Comparing radium to the isotopes that replaced it

The comparison explains both halves of the history: radium was displaced because its physics made it hazardous and un-disposable, and the very same physics is why legacy radium remains a problem long after the clinical practice ended. The shielding needed for radium's chain gamma follows the same point-source and attenuation logic covered in the specific gamma-ray constant and point-source dose.

Clinical Impact

While legacy sources are no longer part of active treatment, their discovery has real operational consequences:

• Facility transitions are high-risk moments. Mergers, closures, relocations, and renovations are when forgotten sources surface. A decommissioning or license-termination project that does not specifically search for legacy sources can miss them—or discover them at the worst possible moment. See decommissioning and license termination.
• An unidentified source halts work. Until a source is characterized and secured, the area around it may need to be restricted, disrupting clinical operations.
• Security and accountability gaps are regulatory findings. A legacy source that is not inventoried, leak tested, or secured is a compliance problem even if it has caused no exposure, and the discovery of an undocumented source raises questions about the facility's overall source accountability. See sealed source inventory and accountability.

The reputational and regulatory cost of mishandling a discovered source generally far exceeds the cost of a proactive search and disposition during a planned transition.

Practical Optimization Tips

If you discover an unknown source

• Do not handle or move it. Maintain distance and restrict access to the area.
• Survey from a safe distance to estimate dose rate and screen for removable contamination, using time, distance, and shielding to minimize exposure.
• Notify the RSO immediately. The RSO leads identification, security, and regulatory notification.
• Secure the source against unauthorized access or removal pending disposition.
• Document everything—location, dose rate, markings, and chain of custody.

Proactive management

• Search deliberately during transitions. Build a legacy-source search into every decommissioning, renovation, and merger plan; interview long-serving staff before they retire.
• Leak test and inventory legacy sealed sources. Sources that have been in storage for years should be leak tested; a radium source that fails a leak test becomes a contamination-control event. See sealed source leak testing.
• Secure per regulation. Apply the security and control requirements of 10 CFR 20.1801–20.1802, and evaluate whether aggregated activity triggers Part 37 source security.
• Plan disposal early through federal programs, because commercial disposal options for radium and many disused sources are limited.

Disposal pathways

Because radium and many disused sources have few commercial disposal routes, facilities typically rely on federal recovery programs:

• DOE/NNSA Off-Site Source Recovery Program (OSRP), administered at Los Alamos National Laboratory, recovers excess, unwanted, abandoned, and orphaned sealed sources—including radium-226—and has been operating since the late 1990s. ⁷
• CRCPD National Orphan Radioactive Material Disposition Program, an NRC-funded program, supports recovery and disposition of orphan material that no longer has a licensed owner. ⁶
• Source Collection and Threat Reduction (SCATR), a CRCPD–DOE cooperative program, can help fund the disposal of unwanted sources still held at licensed facilities. ⁶⁷

Historically, coordinated recovery efforts have consolidated substantial quantities of legacy radium; a National Academies review documented recovery of hundreds of grams of radium through U.S. Public Health Service, EPA, and CRCPD efforts as the medical community moved from radium to cesium-137 and other replacements. ⁸

Regulatory Considerations

The key regulatory fact is that radium-226 is now federally regulated byproduct material, a change that is less than two decades old. For most of the twentieth century, radium was treated as naturally occurring radioactive material outside Atomic Energy Act jurisdiction, regulated—if at all—only by states.

The framework today:

• Energy Policy Act of 2005 (Public Law 109-58), Section 651(e). This statute amended the Atomic Energy Act's definition of byproduct material to include discrete sources of radium-226 (along with accelerator-produced radioactive material and certain other naturally occurring material) when produced, extracted, or used for commercial, medical, or research purposes. ¹
• NRC NARM Rule, 72 FR 55864 (October 1, 2007). The NRC implemented the expanded definition by amending its regulations—including 10 CFR Parts 20, 30, 50, 72, 150, 170, and 171—bringing this material under NRC and Agreement State jurisdiction. ²
• 10 CFR Part 30 governs licensing and general requirements for byproduct material, including possession of discrete radium-226 sources. ³
• 10 CFR Part 20 sets the protection standards, security of licensed material (20.1801–20.1802), and reporting obligations for lost or found sources (for example, 20.2201). ⁴
• 10 CFR Part 37 imposes enhanced security requirements for Category 1 and Category 2 quantities of radioactive material; whether a legacy inventory triggers Part 37 depends on the aggregated activity. ¹¹

Internationally, the IAEA Code of Conduct on the Safety and Security of Radioactive Sources frames the categorization and secure management of disused sources that underlies much of the U.S. recovery infrastructure. ⁹

Agreement States administer their own equivalent programs. Across the states DRPS serves, Florida, Maryland, Virginia, California, Nevada, Pennsylvania, New York, and New Jersey are NRC Agreement States that license and regulate byproduct material—including discrete radium-226—under their own radiation-control rules, while Washington, DC and Delaware are regulated directly by the NRC. A facility must confirm which authority has jurisdiction over a discovered source before relying on any disposition plan; for the jurisdictional basics, see NRC, Agreement States, and FDA jurisdiction, and report incidents per reporting radiation incidents to the NRC.

Frequently Asked Questions (FAQs)

What is a legacy or orphan radioactive source?

A legacy source is a disused sealed source left over from an earlier era of practice—most commonly radium-226 brachytherapy needles, tubes, or plaques. An orphan source is a radioactive source that is outside regulatory control: either uncontrolled and needing removal to protect the public, or controlled but without an identifiable responsible owner. Both still turn up in hospitals during inventories, renovations, and facility closures.

Why is legacy radium-226 hazardous?

Radium-226 has a half-life of about 1,600 years, so it does not decay away in any practical sense. It emits alpha particles and decays through radon-222, a radioactive gas, and gamma-emitting daughters. Aged or corroded radium sources can leak radon and contaminate their surroundings, and the long decay chain produces an external gamma hazard, so a found radium source is both a contamination and an external-dose concern.

Who regulates radium-226 now?

Historically radium was naturally occurring material outside federal Atomic Energy Act jurisdiction. The Energy Policy Act of 2005 changed that: discrete sources of radium-226 produced or used for commercial, medical, or research purposes became byproduct material. The NRC implemented this through the 2007 NARM rule, so radium-226 is now regulated by the NRC or by Agreement States under byproduct-material rules.

What should I do if I find an unknown radioactive source?

Do not handle or move it. Secure the area, survey from a safe distance to characterize dose rate, restrict access, and notify your Radiation Safety Officer immediately. The RSO coordinates identification, security, regulatory notification to the NRC or Agreement State, and arranges recovery or disposal. Treat an unidentified source as both an external-dose and a contamination hazard until proven otherwise.

How are legacy and orphan sources disposed of?

Disposal is usually arranged through federal recovery programs because commercial disposal paths for radium and many disused sources are limited. The DOE/NNSA Off-Site Source Recovery Program recovers excess, unwanted, abandoned, and orphaned sealed sources, including radium-226, and the CRCPD administers an NRC-funded national program for orphan material and a cooperative program (SCATR) that can help fund disposal of unwanted sources at licensed facilities.

Do legacy sources need leak testing and security?

Yes. Sealed sources in possession generally require periodic leak testing and physical security under 10 CFR Part 20 and license conditions, and higher-activity sources may fall under 10 CFR Part 37 security requirements. Legacy sources that have been in storage for years should be leak tested and inventoried; a corroded or leaking radium source requires contamination control and prompt action.

Who can help a facility manage legacy and orphan sources?

A qualified medical physicist or health physicist and the facility's RSO should lead identification, surveys, security, regulatory notification, and disposal coordination. DRPS supports facilities with radioactive material license support, RSO program guidance, and source management across its service areas.

Key Takeaways

• Legacy radium is a current problem. Radium-226 brachytherapy sources still surface in hospitals, and because the isotope's half-life is about 1,600 years, they are as active as the day they were made. ¹⁰
• It is a dual hazard. Radium is both a contamination risk (radon leakage from aged encapsulation) and an external gamma risk (from decay-chain daughters). ¹⁰
• The rules changed in 2005. Discrete radium-226 sources became byproduct material under the Energy Policy Act of 2005, implemented by the NRC's 2007 NARM rule. ¹²
• Handle discoveries methodically. Do not touch; secure, survey, notify the RSO, and document—then coordinate regulatory notification and disposal.
• Use federal recovery programs. DOE OSRP, the CRCPD national orphan program, and SCATR are the practical disposal routes for radium and many disused sources. ⁶⁷
• Search proactively during transitions. Build legacy-source searches into decommissioning, renovation, and merger plans.

Conclusion

Legacy and orphan sources are the radiation-safety equivalent of buried infrastructure: out of sight, easy to forget, and expensive to mishandle. Radium-226 is the defining example—clinically obsolete for decades, physically unchanged, and now firmly within the federal byproduct-material framework.

A facility that treats legacy sources proactively—searching for them during transitions, leak testing and securing what it finds, and planning disposition through the federal recovery programs—converts a potential emergency into a routine, documented process. The RSO and a qualified physicist should own this work, because the alternative is discovering a century-old curie of radium with no plan for what comes next.

How DRPS Can Help

Diagnostic Radiation Physics Services helps facilities identify, characterize, secure, and disposition legacy and orphan sources. This includes source surveys and leak testing, security and inventory review, regulatory notification support, and disposal coordination through federal recovery programs, delivered alongside radioactive material license support, RSO program guidance, and radiation shielding design where storage or handling shielding is needed.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware. If your facility is merging, renovating, or decommissioning—or if a source has already turned up—contact us through our contact page before anyone handles it.

Related Resources

• Sealed source inventory and accountability
• Sealed source leak testing
• Securing licensed material (10 CFR 20.1801–1802)
• Radioactive source security under Part 37
• Decommissioning and license termination
• NRC, Agreement States, and FDA jurisdiction
• Radioactive material license support
• Radiation Safety Officer consulting

References

1. U.S. Congress. Energy Policy Act of 2005, Public Law 109-58, Section 651(e) (amending the definition of byproduct material in the Atomic Energy Act). 2005. congress.gov
2. U.S. Nuclear Regulatory Commission. Requirements for Expanded Definition of Byproduct Material; Final Rule. 72 FR 55864; October 1, 2007 (the "NARM rule"). federalregister.gov
3. U.S. Nuclear Regulatory Commission. 10 CFR Part 30: Rules of General Applicability to Domestic Licensing of Byproduct Material. ecfr.gov
4. U.S. Nuclear Regulatory Commission. 10 CFR Part 20: Standards for Protection Against Radiation. ecfr.gov
5. U.S. Nuclear Regulatory Commission. Orphan Sources and Protecting the Public (orphan source definition and program overview). nrc.gov
6. Conference of Radiation Control Program Directors. National Orphan Radioactive Material Disposition Program and Source Collection and Threat Reduction (SCATR) Program. crcpd.org
7. U.S. Department of Energy, National Nuclear Security Administration. Off-Site Source Recovery Program (OSRP), Los Alamos National Laboratory. osrp.lanl.gov
8. National Research Council. Radiation Source Use and Replacement: Abbreviated Version. Washington, DC: The National Academies Press; 2008. nap.nationalacademies.org
9. International Atomic Energy Agency. Code of Conduct on the Safety and Security of Radioactive Sources. Vienna: IAEA; 2004. iaea.org
10. International Commission on Radiological Protection. ICRP Publication 107: Nuclear Decay Data for Dosimetric Calculations. Ann ICRP. 2008;38(3). icrp.org
11. U.S. Nuclear Regulatory Commission. 10 CFR Part 37: Physical Protection of Category 1 and Category 2 Quantities of Radioactive Material. ecfr.gov